Summary
Martin Szyska is a computational biologist specializing in immuno-oncology with eight years of experience combining cancer immunology and NGS-driven bioinformatics to identify therapeutic targets. Currently at Bayer, he brings hands-on immunological expertise to biomarker and target selection, building on prior roles at Charité where he led NGS analyses and lab operations for T-cell therapy research. Trained as a Dr.-Ing. in immunology and a Diplom-Ingenieur in medical biotechnology, he pairs rigorous wet-lab pedigree with practical data-science skills (Python, Linux toolkits, visualization) developed during an entrepreneurial stint as a data analyst. He has a track record of translating complex in vivo and flow-cytometry experiments into computational insights, and an unusual research finding linking thrombopoietin levels to long-lived plasma cell seeding hints at his knack for spotting non-obvious biological connections. Based in Berlin, he thrives at the interface of hands-on immunology and scalable computational analysis to accelerate cancer therapeutics.
8 years of coding experience
11 years of employment as a software developer
Diplom-Ingenieur, Medical Biotechnology, 1,5, Diplom-Ingenieur, Medical Biotechnology, 1,5 at Technische Universität Berlin
Dr.-Ing. (Doctor of Engeneering), Immunology, Magna cum Laude, Dr.-Ing. (Doctor of Engeneering), Immunology, Magna cum Laude at Deutsches Rheumaforschungszentrum Berlin
German, English, Portuguese, Spanish, French